|
|
||||||||
1From the Beijing Institute of Ophthalmology and the 3Department of Ophthalmology, Beijing TongRen Eye Center, Capital University of Medical Sciences, Beijing, China; and the 2Department of Immunology, General Hospital of PLA, Beijing, China.
PURPOSE. The purpose of this study was to determine the optimal conditions for prolonging corneal allograft survival by inducing anergy with the superantigen staphylococcal enterotoxin B (SEB).
METHODS. A rat model of penetrating keratoplasty, whereby Fisher344 donor corneas are implanted into Lewis recipients, was used to evaluate the effects of SEB on inhibiting immune-mediated allograft rejection. To induce anergy, SEB was injected into the peribulbar space of Lewis rats. Furthermore, histopathology and immunofluorescent staining were used to examine the levels of infiltrating CD4+ and CD8+ T lymphocytes and NK1.1+ lymphocytes.
RESULTS. By administering SEB, at doses of 90 or 120 µg/kg 7 days before and after keratoplasty, we suppressed the episode of corneal graft rejection for a median of 12 and 30 days, respectively. In contrast, rejection was observed when 30 or 60 µg/kg of SEB was administered. After SEB injections, lymphocyte infiltration into the corneal grafts was reduced, and the expression of NK1.1+ lymphocytes was enhanced, suggesting that anergy may be occurring. Also, there were no differences in the number of infiltrating CD4+ and CD8+ T lymphocytes cells between the control group and groups injected with 30 and 120 µg/kg SEB on postoperative days 10 and 30.
CONCLUSIONS. Inducing anergy with the superantigen SEB prolonged corneal graft survival in a rat model of penetrating keratoplasty. Therefore, these results support the possibility of prolonging corneal allograft survival in a clinical setting by preventing immune-mediated rejection through the administration of the superantigen SEB.
This article has been cited by other articles:
![]() |
Y Jie, Z Pan, Y Chen, Y Wei, W Zhang, Y Wu, H Peng, and L Xu Non-specific tolerance induced by staphylococcal enterotoxin B in treating high risk corneal transplantation in rats Br. J. Ophthalmol., March 1, 2005; 89(3): 364 - 368. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |